<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>HTG Molecular Diagnostics</title>
	<link>http://www.htgmolecular.com</link>
	<description></description>
	<lastBuildDate>Fri, 03 Feb 2012 19:49:59 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.2.1" -->

	<item>
		<title>HTG Luncheon Presentation</title>
		<description><![CDATA[Multiplexing FFPE Samples in Your Lab and Achieving Meaningful Results BJ Kerns, Senior VP HTG Molecular BJ Kerns has been selected to speak on the benefits of qNPA [..]]]></description>
		<link>http://www.htgmolecular.com/htg-luncheon-presentation/</link>
			</item>
	<item>
		<title>USCAP 2012</title>
		<description><![CDATA[March 17-23, 2012 Vancouver Convention Center Vancouver, BC, Canada (booth # TBD)]]></description>
		<link>http://www.htgmolecular.com/uscap-2012/</link>
			</item>
	<item>
		<title>CHI&#8217;s Molecular Med Tri-Con</title>
		<description><![CDATA[Feb 19-23, 2012 Booth # 300 Moscone North Convention Center San Francisco, CA HTG Luncheon Presentation Multiplexing FFPE Samples in Your Lab and Achieving Meaningful Results BJ Kerns, [..]]]></description>
		<link>http://www.htgmolecular.com/chis-molecular-med-tri-con/</link>
			</item>
	<item>
		<title>Industry Views: An Interview with HTG Molecular Diagnostics</title>
		<description><![CDATA[ADVANCE Magazine interviewed HTG Molecular's President and CEO T.J. Johnson about the future of the clinical laboratory. Read TJ's insight into the future of the clinical lab and how HTG is poised to meet clients' needs and provide solutions to today's  universally recognized industry obstacles. <a href="http://www.htgmolecular.com/an-interview-with-htg-molecular-diagnostics/">Read more &#187;</a>]]></description>
		<link>http://www.htgmolecular.com/an-interview-with-htg-molecular-diagnostics/</link>
			</item>
	<item>
		<title>Harry A. George</title>
		<description><![CDATA[Chairman Mr. George has more than 27 years of experience with successful rapid growth technology-related companies, serving as founder, operating officer, or investor. Mr. George co-founded Interleaf, a [..]]]></description>
		<link>http://www.htgmolecular.com/harry-a-george/</link>
			</item>
	<item>
		<title>Peter Bisgaard</title>
		<description><![CDATA[Peter Bisgaard is a partner in Novo Ventures Novo A/S and has been with the firm since 2001. Prior to joining Novo A/S, Peter directed strategy development, mergers, [..]]]></description>
		<link>http://www.htgmolecular.com/peter-bisgaard/</link>
			</item>
	<item>
		<title>Simeon J. George</title>
		<description><![CDATA[Mr. George joined SR One in 2007 where he currently leads investment activities on the West Coast. He also serves as a member of the boards of directors [..]]]></description>
		<link>http://www.htgmolecular.com/simeon-j-george/</link>
			</item>
	<item>
		<title>Donald Grimm</title>
		<description><![CDATA[Mr. Grimm’s distinguished career at Eli Lilly &#38; Company included a variety of key management positions in the company’s pharmaceutical, biotechnological and medical device businesses. He served as [..]]]></description>
		<link>http://www.htgmolecular.com/donald-grimm/</link>
			</item>
	<item>
		<title>Molly Hoult</title>
		<description><![CDATA[Ms. Hoult joined Fletcher Spaght, Inc. in 2009. She has over 20 years of biotechnology, life science and healthcare experience as a consultant and in marketing and business [..]]]></description>
		<link>http://www.htgmolecular.com/molly-hoult/</link>
			</item>
	<item>
		<title>Tim (TJ) Johnson</title>
		<description><![CDATA[Mr. Johnson joined HTG Molecular in January 2008 from LVC Consulting, where he was a partner. Prior to LVC, Mr. Johnson served as a senior vice president with [..]]]></description>
		<link>http://www.htgmolecular.com/tim-tj-johnson-2/</link>
			</item>
</channel>
</rss>

